AceLink Therapeutics
PrivateLast Round
Series A
May 1, 2021
Total Funding Raised
$10M
Company Overview
AceLink Therapeutics operates in Healthcare & Life Sciences and is based in Newark, California. Its latest recorded funding round was a Series A round in May 2021.
AceLink Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for diseases of glycolipid metabolism.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AceLink Therapeutics Comparables
Compare AceLink Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Azafaros | 80% | |
| Idorsia Ltd. | 75% | |
| Sanofi | 72% |
For institutional investors. Book with your work email.
AceLink Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 1, 2021 | ||||
| Seed | Jul 1, 2019 |
For institutional investors. Book with your work email.
AceLink Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaitai Capital | Seed, Series A |
| Viva BioInnovator | Seed, Series A |
| Shengshan Asset Management | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors increased 111% MoM, reaching 1.5K.
- May 2, 2025
Monthly visitors grew 70% MoM, reaching 1K.
For institutional investors. Book with your work email.
AceLink Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AceLink Therapeutics's valuation, stock price, and market status.
Is AceLink Therapeutics a public or private company?
AceLink Therapeutics is a private company.
What is the current stock price of AceLink Therapeutics?
AceLink Therapeutics is a private company, so its shares have no public market price. Caplight tracks AceLink Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AceLink Therapeutics worth (valuation)?
Valuation information for AceLink Therapeutics is not publicly available.
Can I buy AceLink Therapeutics stock?
AceLink Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AceLink Therapeutics's last funding round?
AceLink Therapeutics's most recent funding round was Series A on May 1, 2021.
Who are the main investors in AceLink Therapeutics?
Key investors in AceLink Therapeutics include Kaitai Capital, Viva BioInnovator, Shengshan Asset Management.
Will AceLink Therapeutics IPO soon?
No public IPO plans have been announced for AceLink Therapeutics.
How can I track AceLink Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in AceLink Therapeutics's shares on secondary markets.